1. HORMAD1 drives spindle assembly checkpoint defects and sensitivity to multiple mitotic kinases. (October 2022) Authors: Walker, C.; Weekes, D.; Torga, G.; Quist, J.; Trendell, J.; Hitchens, L.; Martin, A.; Davidson, K.; Kollarovic, G.; Grigoriadis, A.; Pines, J.; Pettitt, S.; Lord, C.; Tutt, A. Journal: European journal of cancer Issue: Volume 174(2022)Supplement 1 Page Start: S66 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. SP-0258: Potentiation of anti-tumor immune effects by PARP Inhibitors. (November 2020) Authors: Chabanon, R.; Muirhead, G.; Krastev, D.; Adam, J.; Garrido, M.; Morel, D.; Dorvault, N.; Pettitt, S.; Tutt, A.N.J.; Marabelle, A.; Soria, J.C.; Lord, C.J.; Postel-Vinay, S. Journal: Radiotherapy and oncology Issue: Volume 152(2020)Supplement 1 Page Start: S132 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗